## **Core Concept**
Low molecular weight heparins (LMWHs) are a class of anticoagulant medications used to prevent and treat thrombosis. They work by enhancing the activity of antithrombin III, a natural anticoagulant in the body. This interaction primarily inhibits coagulation factors.

## **Why the Correct Answer is Right**
The correct answer, **Factor Xa**, is inhibited by low molecular weight heparins. LMWHs primarily exert their anticoagulant effect by potentiating the inhibition of **Factor Xa** and to a lesser extent, **Factor IIa (thrombin)**, by antithrombin III. The inhibition of Factor Xa prevents the conversion of prothrombin to thrombin, thereby reducing thrombin generation and subsequent clot formation.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is blank and cannot be evaluated.
- **Option C:** This option is blank and cannot be evaluated.
- **Option D:** This option is blank and cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that low molecular weight heparins have a more predictable dose-response relationship compared to unfractionated heparin, which allows for less frequent monitoring and dose adjustment. They are also associated with a lower risk of heparin-induced thrombocytopenia.

## **Correct Answer:** . **Factor Xa**